Fig. 2From: Impact of HER2 Expression on the Prognosis of Muscle-Invasive Bladder Cancer Patients Treated with Bladder-Preservation Comprehensive TherapyImmunohistochemical staining of HER2 expression levels at 0, 1 + , 2 + , and 3 +Back to article page